Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Cancer. 2014 Aug 25;121(1):51–59. doi: 10.1002/cncr.28981

Figure 3. Normalized levels of miR-15b measured in multiple serum samples from recurrent patients over time.

Figure 3

Serum miR-15b levels were measured in a subset of patients. Recurrent patients (n=34) are shown. Each patient had at least two serum samples, drawn at different time points, tested. t=0 at date of first recurrence. Serum level of miR-15b increases leading up to recurrence.